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Thrombin, a serine protease involved in the blood coagulation cascade has been shown
to affect neural function following blood-brain barrier breakdown. However, several
lines of evidence exist that thrombin is also expressed in the brain under physiological
conditions, suggesting an involvement of thrombin in the regulation of normal brain
functions. Here, we review ours’ as well as others’ recent work on the role of thrombin
in synaptic transmission and plasticity through direct or indirect activation of Protease-
Activated Receptor-1 (PAR1). These studies propose a novel role of thrombin in synaptic
plasticity, both in physiology as well as in neurological diseases associated with increased
brain thrombin/PAR1 levels.
Keywords: thrombin, proteases activated receptor 1 (PAR1), clotting factors, long term potentiation, synaptic
plasticity, hippocampus
Thrombin in the Blood and in the Brain
Coagulation is a fundamental biological process, by which cellular as well as protein components
in the blood form a clot to stop bleeding from injured vessels (Kalz et al., 2014). It consists of a
cascade of molecular events leading to the activation of thrombin, which catalyzes the conversion
of fibrinogen to fibrin, the building blocks of the hemostatic plug (Figure 1; Siller-Matula et al.,
2011; Lippi et al., 2012). Thrombin is a serine protease which is activated by the enzymatic cleavage
of two sites on prothrombin by activated Factor X (FXa; Furie and Furie, 2005). The activity of FXa
is enhanced by binding to activated Factor V (FVa, which forms the prothrombinase complex with
FXa; Figure 1; Furie and Furie, 2005).
Prothrombin is produced in the liver and is post-translationally modified in a vitamin K-
dependent reaction that converts 10 glutamic acids on prothrombin to gamma-carboxyglutamic
acid (Gla; Huang et al., 2003). In the presence of Ca2+, the Gla residues promote the binding of
prothrombin and other coagulation factors to exposed phospholipid bilayers, which accelerates but
also restricts clotting procedure in a dose-dependent manner to injured sites (Huang et al., 2003).
Deficiency of vitamin K or administration of the anticoagulant warfarin, an inhibitor of the vitamin
k epoxide reductase, inhibits the production of Gla residues and slows the activation of coagulation
(Huang et al., 2003). As part of its activity in the coagulation cascade, thrombin also promotes
platelet-activation and aggregation (Figure 1; Borissoff et al., 2011).
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FIGURE 1 | Coagulation, anticoagulation and fibrinolysis
maintain a delicate physiological balance between bleeding
and thrombosis. Schematic diagram of the coagulation cascade
(red), Protein C pathway (blue) and fibrinolysis (green). See main text
for more detailed explanation. Abbreviations: TFPI, Tissue Factor
Pathway Inhibitor; PAR, Proteases activated receptors; EPCR,
Endothelial Protein C Receptor; PA, Plasminogen Activator; PAI,
Plasminogen Activator Inhibitor.
Conversely, thrombin initiates a feedback mechanism which
leads to its own inhibition. Once bound to thrombomodulin,
an integral membrane protein expressed by endothelial cells,
it increases its affinity to and activates Protein C. Activated
Protein C (aPC) in turn leads to the inactivation of the
prothrombinase complex (= FXa + FVa) at sites with an intact
endothelium (Figure 1; Mosnier et al., 2014). In addition,
freely circulating thrombin is blocked by antithrombin-III
(Figure 1), a serine protease inhibitor, which is enhanced in
its activity by the anticoagulant heparin (Jo et al., 2014). Taken
together, blood thrombin activity is tightly regulated by a set
of positive- and negative-feedback mechanisms, which promote
clotting at injured sites and prevent coagulation at healthy sites.
Considering its key role in the coagulation cascade it is not
surprising that novel oral anticoagulants (NOACs) have been
developed that act as direct (i.e., dabigatran) or indirect thrombin
inhibitors (i.e., rivaroxaban and apixaban, via FXa inhibition)
(Levy et al., 2014).
Beyond its role in the dynamic process of blood clot
formation, thrombin has pronounced pro-inflammatory effects
(Esmon, 2014). Acting via specific cell membrane receptors,
the Protease-Activated Receptors (PARs), which are abundantly
expressed in all arterial vessel wall constituents, thrombin
has the potential to exert pro-atherogenic actions, such as
leukocyte migration, cellular proliferation, regulation of vascular
permeability and tone, platelet-activation, and edema formation
(Coughlin, 2000, 2001; Sambrano et al., 2001; Chen and Dorling,
2009; Schuepbach et al., 2009; Spiel et al., 2011). PARs belong
to a unique family of G protein-coupled receptors (Luo et al.,
2007). Their activation is initiated by an irreversible, site-
specific proteolytic cleavage in the N-terminal extracellular
region, which uncovers a tethered ligand activating Gαq/11,
Gαi/o, or Gα12/13 -proteins (Coughlin, 2000; Macfarlane et al.,
2001; Traynelis and Trejo, 2007). Activation of PARs can recruit
multiple intracellular signaling pathways depending on the
activating ligand (Russo et al., 2009). This agonist-biased signal
transduction and the resulting diversity of intracellular signaling
pathways appear to be crucial for the multiple actions of PARs
(Russo et al., 2009; Bourgognon et al., 2013).
Interestingly, PARs are also expressed in the brain and while
PAR2 represents a class of trypsin/tryptase-activated receptors,
PAR1, PAR3, and PAR4 are most effectively activated by
thrombin (Gingrich and Traynelis, 2000). In the brain, PAR1
has been detected in both neurons and astrocytes, with the
latter demonstrating stronger immunohistochemical signal in
human brain tissue (Junge et al., 2004). High levels of PAR1
are detected in the hippocampus, cerebral cortex, and striatum
of humans (Junge et al., 2004). While the precise molecular
pathways activated by neural PAR1 are yet under investigation, in
the brain PAR1-activation has been shown to modulate synaptic
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transmission and plasticity through the enhancement of N-
methyl-D-aspartate receptor (NMDAR) currents (Gingrich et al.,
2000; Lee et al., 2007; Maggio et al., 2008; Becker et al., 2014;
Vance et al., 2015). In addition, PAR1-deficient animals have
been reported to have alterations in hippocampus-dependent
learning and memory processes (Almonte et al., 2007, 2013),
indicating that PAR1 plays a critical role in memory formation
and synaptic plasticity under physiological conditions.
A variety of neurological conditions have been associated with
changes in the expression of PAR1 in the brain. In Parkinson’s
disease, a significant increase in the number of astrocytes
expressing PAR1 has been reported in the substantia nigra pars
compacta (Ishida et al., 2006). In addition, upregulation of PAR1
in astrocytes has been observed in HIV encephalitis (Boven et al.,
2003), implicating this receptor in neuroinflammatory responses.
This idea is supported by the evidence of elevated levels of
thrombin in an experimental model of multiple sclerosis (Beilin
et al., 2005) and other inflammatory brain diseases (Chapman,
2006). Stimulation of PAR1 by thrombin causes proliferation of
glia and produces reactive gliosis, infiltration of inflammatory
cells, and angiogenesis (Striggow et al., 2001). Finally, expression
of PAR1 is increased in experimental models of Alzheimer’s
disease (Pompili et al., 2004) and brain ischemia (Striggow et al.,
2001).
Both thrombin and its inactive precursor prothrombin have
been also detected in the brain (Dihanich et al., 1991; Xi et al.,
2003). Prothrombin mRNA shows the highest expression in the
cerebral cortex and a moderate expression in the hippocampus
and cerebellum (Figure 2A; Dihanich et al., 1991). In the
hippocampus pronounced immunohistochemical labeling of
thrombin is observed in pyramidal cell layers, while lower
(clustered) thrombin signal is seen in the fiber-layers (Figure 2B).
Although the precise cellular source of thrombin in the brain
and the molecular mechanisms responsible for its formation
and release warrant further investigation, experimental evidence
has been provided that neural prothrombin expression and
thrombin activity are highly regulated under physiological and
pathological conditions (Xi et al., 2003; Stein et al., 2015). Hence,
the molecular machinery of thrombin/PAR1 signaling is detected
not only in the vascular system but also present in brain tissue,
where it seems to act as a modulator of neural plasticity.
Concentration-Dependent Effects
of Thrombin on Synaptic Plasticity
Long term potentiation (LTP) or depression (LTD) of synaptic
strength, homeostatic plasticity andmetaplasticity are considered
to play important roles for the ability of the brain to effectively
learn and adapt to novel challenges (Malenka, 2003; Turrigiano,
2012; Hulme et al., 2013). Consistent with the crucial role of
synaptic plasticity in brain function (and similar to the blood
coagulation cascade), plasticity is a highly regulated process
composed of multiple feed-forward and feed-back mechanisms.
This situation tunes neural networks in a way that promotes
stability, but at the same time allows for rapid and site-specific
responses; including changes in the threshold, direction and
FIGURE 2 | Prothrombin and Thrombin are expressed in the
brain. (A) Prothrombin mRNA measured by (RT)qPCR in cerebellum,
hippocampus and cerebral cortex of C57BL/6J mice (primers: 5′
CCGAAAGGGCAACCTAGAGC, 5′ GGCCCAGAACACGTCTGTG). The
results were normalized to HPRT gene expression within the same
cDNA sample and calculated using the ∆CT method with values
being expressed as 2−∆Ct. (B) Immunostaining for thrombin (Santa
Cruz Biotech, goat polyclonal IgG, cleaved thrombin HC (m361),
sc-23335; dilution 1:100 in PBS-based solution) and NeuN (Millipore,
mouse monoclonal, MAB377, dilution 1:1000 in PBS-based solution)
in the dorsal hippocampus of adult C57BL/6J-mice. Thrombin
labeling is predominantly detected in the pyramidal cell layer (PCL) of
CA1. The fiber-layers (e.g., stratum radiatum, rad) display weaker but
more clustered immunohistochemical signal for thrombin. Scale bar at
low magnification = 300 µm; scale bar at higher magnification =
20 µm.
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FIGURE 3 | Concentration-dependent effects of thrombin on
synaptic plasticity. High levels of thrombin cause a slow onset
NMDAR-dependent LTP by direct activation of PAR1. Low concentrations
of thrombin activate Protein C which binds to EPCR and activates PAR1 to
induce metaplasticity, i.e., a reduction in the LTP threshold [by recruitment
of L-type voltage gated calcium channels (L-VGCC), metabotropic
glutamate receptors 5 (mGluR5), sphingosine-1-phosphate (S1P), and
internal calcium stores]. For further details refer to the main text and Maggio
et al. (2013c).
duration of synaptic events. Conceptually this stable dynamic
state of synaptic plasticity is comparable to the blood coagulation
cascade, which is kept in a delicate balance between bleeding and
site-specific thrombosis. Therefore, it has been hypothesized that
similar signaling pathways are employed in blood coagulation
and synaptic plasticity.
Indeed, robust experimental evidence exists that thrombin
and other coagulation factors are involved in the regulation of
LTP in the hippocampus (Gingrich et al., 2000; Almonte et al.,
2007; Maggio et al., 2008, 2013b,c; Mannaioni et al., 2008; Hamill
et al., 2009). Furthermore, it has been shown that PAR1-signaling
mediates thrombin-induced synaptic plasticity, which requires
the activation of NMDARs (Lee et al., 2007; Han et al., 2011; Oh
et al., 2012; Park et al., 2013).
In a recent attempt to shed more light on the physiological
vs. pathological functions of thrombin and PAR1 in the brain,
we studied the effects of different concentrations of thrombin
and PAR1 activating peptide (PAR1-AP) on hippocampal LTP.
This set of experiments disclosed that thrombin regulates
the threshold for synaptic plasticity in a concentration-
dependent manner (Figure 3; Maggio et al., 2013c). Specifically,
[Thrombin]high induced an NMDAR-dependent slow onset
LTP, which occluded the ability of neurons to express further
LTP (Maggio et al., 2008, 2013c). Conversely, [Thrombin]low
promoted L-type voltage gated calcium channel (L-VGCC),
metabotropic glutamate receptor 5 (mGluR-5), and intracellular
Ca2+ store-dependent LTP, which required aPC and the
activation of the Endothelial Protein C Receptor (EPCR, detected
on astrocytes and neurons) (Maggio et al., 2013c). In a follow-
up study, we further clarified the role of aPC and EPCR in
regulating [Thrombin]low-mediated synaptic plasticity (Maggio
et al., 2014). We demonstrated that aPC induces metaplasticity
and thereby enhances the ability to induce LTP (Maggio et al.,
2014). This effect of aPC is mediated by EPCR-dependent
PAR1-activation that triggers the production of Sphingosine-1-
Phosphate (S1P). In turn, the activation of S1P-receptor 1 and
intracellular Ca2+ stores, ultimately lead to a reduction in the
LTP threshold (Maggio et al., 2014). Hence, high concentrations
of thrombin saturate the ability of neurons to express further LTP
via direct PAR1-activation (Maggio et al., 2008), while at low
concentration thrombin mediates metaplasticity by enhancing
LTP via aPC-EPCR mediated PAR1-signaling (Figure 3;
Maggio et al., 2013c).
This finding is of considerable interest in clinical settings of
cerebrovascular events: upon blood-brain barrier (BBB) opening,
exposure to blood-derived thrombin and aPC could interfere
with endogenous, i.e., neural thrombin/aPC mediated synaptic
plasticity. On the one hand high thrombin concentrations may
affect the ability of the brain to use LTP-like plastic processes
for acquisition of new ‘‘memories’’, due to the [Thrombin]high-
mediated saturation of LTP. On the other hand aPC/PAR1
mediated synaptic plasticity (Maggio et al., 2013c, 2014), could
facilitate LTP through other mechanisms andmay counteract the
[Thrombin]high effect (Maggio et al., 2008). The precise role and
interplay of thrombin vs. aPC mediated synaptic plasticity under
physiological and pathological conditions and the biological
consequences for the course of diseases is currently under
investigation.
PAR1-Activation Affects Homeostatic
Synaptic Plasticity
To learn more about the role of thrombin/PAR1-signaling under
pathological conditions and to study its role in other forms
of synaptic plasticity, we used the entorhinal denervation in
vitro model (Del Turco and Deller, 2007) and assessed the role
of PAR1 in denervation-induced homeostatic synaptic plasticity
(Vlachos et al., 2012). This model takes advantage of the highly
organized entorhino-hippocampal projection, which originates
in the entorhinal cortex, forms the perforant pathway, and
terminates in the hippocampus. Lesioning this fiber tract results
in the partial denervation of neurons in the hippocampus,
without directly damaging the dendritic tree of target neurons
(Müller et al., 2010). In turn, neurons respond to the loss
of entorhinal input with a slow adaptive, i.e., compensatory
increase in excitatory synaptic strength (Vlachos et al., 2012,
2013a,b), which is considered to play an important role in
stabilizing the activity of neuronal networks under physiological
and pathological conditions (Marder and Goaillard, 2006;
Maffei and Fontanini, 2009; Turrigiano, 2012; Vitureira et al.,
2012). While the presence of PAR1 was not required for
homeostatic plasticity of excitatory synapses to occur, our study
revealed that PAR1-activation occludes the ability of partially
denervated neurons to increase their excitatory synaptic strength
in a compensatory manner (Becker et al., 2014). Thus our
results provided first experimental evidence that PAR1 activity
affects neural homeostasis, which could be of relevance for
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neurological diseases associated with increased brain thrombin
concentrations, neuronal cell loss and denervation of connected
brain regions (see also Maggio and Vlachos, 2014).
The Role of Thrombin/PAR1-Signaling
in Ischemic LTP
Finally, in a recent study we demonstrated that thrombin/PAR1-
signaling has a fundamental role in oxygen glucose deprivation
(OGD)-mediated alterations in synaptic plasticity (Stein et al.,
2015). A brief (i.e., a few minutes) deprivation of oxygen and
glucose, as seen for example in the early stage of acute ischemia
or transient ischemic attack, potentiates synaptic transmission
at hippocampal CA3-CA1 synapses in an NMDAR-dependent
manner and induces ischemic LTP (iLTP) without causing
neuronal cell death (Crépel et al., 1993; Hsu and Huang, 1997;
Calabresi et al., 2003). It has been proposed that iLTP could
have amajor impact on the functional reorganization of neuronal
networks during the early phase of ischemic stroke (Calabresi
et al., 2003). In this context, we were able to demonstrate that
OGD increases thrombin activity in neural tissue, i.e., in acute
hippocampal slices, and triggers the induction of iLTP.Moreover,
we showed that the induction of iLTP impairs the ability of
neurons to express further LTP in a thrombin/PAR1-dependent
fashion. Indeed, iLTP was blocked when thrombin activity or
PAR1 signaling were inhibited and the ability of neurons to
express LTP was rescued (Stein et al., 2015). We concluded from
this series of experiments that iLTP resembles a [Thrombin]high-
mediated LTP and hypothesized that counteracting thrombin
signaling in the brain during the acute phase of stroke may
improve synaptic plasticity (Stein et al., 2015).
Together, these studies provided robust experimental
evidence that PAR1-signaling (which is activated, e.g., by
thrombin or aPC) is involved in the regulation of distinct forms
of synaptic plasticity under physiological and pathological
conditions.
A Role for Thrombin/PAR1 in
Epileptogenesis
Although serine proteases are expressed at very low
concentration in neural tissue (Luo et al., 2007), their levels
increase significantly in the brain following BBB breakdown. In
this condition, a large, non-selective increase in the permeability
of brain capillaries and tight junctions takes place, such that
high molecular weight proteins (Ballabh et al., 2004) and other
blood components gain access to the brain. This particular event
occurs in several neurological conditions (Ballabh et al., 2004;
Tomkins et al., 2008), including hemorrhagic/ischemic stroke
(Hjort et al., 2008; Bang et al., 2009) and traumatic brain injury
(Barzó et al., 1997; Tomkins et al., 2008; Itzekson et al., 2014).
Even though there is a paucity of information concerning the
amount of thrombin crossing the BBB, it has been reported that
thrombin levels increase more than 200 fold (from 100 pM to
25 nM) in the cerebrospinal fluid of patients with subarachnoid
hemorrhage (Suzuki et al., 1992). In addition, if bleeding occurs
directly within the brain tissue, active thrombin and other
proteases freely diffuse into the brain parenchyma until blood
coagulation closes off the injured vessels (Suzuki et al., 1992).
A direct consequence of the contact of thrombin with the brain
tissue is the onset of seizures (Lee et al., 1997). In 1997, Lee et
al. reported that intracerebral injections of thrombin results in
focal motor seizures. Interestingly, the injection of thrombin
together with its inhibitor alpha-(2-naphthylsulfonyl-glycyl)-
4-amidinophenylalaninepiperidide (alpha-NAPAP) prevented
both clinical and electrographic seizures (Lee et al., 1997).
Similarly, mice engineered to lack Nexin-1, an endogenous
thrombin inhibitor, have an increased susceptibility for kainic
acid-induced seizures (Luthi et al., 1997).
Following this line of evidence we were able to demonstrate
that thrombin-induced seizures are mediated by activation of
PAR1 (Maggio et al., 2008). In hippocampal slices, thrombin
at a concentration of 5 nM (1 U/ml) increased spontaneous
firing of CA3 pyramidal cells (Maggio et al., 2008). In order
to examine whether thrombin facilitates the onset of epileptic
discharges in conditions mimicking BBB breakdown in the
slice (Chen and Swanson, 2003; Beart and O’Shea, 2007), we
exposed neurons to thrombin in presence of elevated [K+]o
or glutamate. In normal slices, addition of 4 mM [K+]o did
not produce any noticeable spontaneous seizures, which were
clearly seen when [K+]o were increased to 15 mM. Similarly,
500 µM but not 100 µM glutamate produced spontaneous
seizure-like activity in the slice. Remarkably, thrombin facilitated
the response to the lower concentration of [K+]o (4 mM)
and glutamate (100 µM) to produce seizure-like activity. This
facilitatory action of thrombin on the production of seizure-
like activity was mediated by PAR1, since it was mimicked
by PAR1-AP and blocked by the PAR1-inhibitor SCH79797.
However, it did not depend on NMDARs as it was not affected
by the selective NMDAR-inhibitors ifenprodil or by 2R-amino-
5-phosphonovalericacid (APV), indicating that [Thrombin]high-
mediated LTP does not explain the acute effects of thrombin
on seizure-induction (Maggio et al., 2008). While thrombin
induced epileptogenesis seems to be NMDAR-independent, it is
possible that thrombin could also indirectly modulate synaptic
transmission, e.g., through thrombin-mediated proteolysis and
remodeling of the extracellular matrix (e.g., Dityatev, 2010).
More recently, Isaeva et al. (2012) exposed hippocampal
slices prepared from young postnatal rats (P6 to P15) to large
concentrations of thrombin (10 U/ml), to find that thrombin
depolarizes membrane potential of neurons and produces a
hyperpolarizing shift of tetrodotoxin-sensitive INap through a
PAR1-mediated mechanism (Isaeva et al., 2012). In addition,
we have reported that thrombin affects synaptic transmission
in hippocampal CA3 neurons by enhancing both frequency and
amplitude of mEPSCs, while reducing frequency and amplitude
of mIPSCs (Maggio et al., 2013b). Together, these studies showed
a pro-epileptic effect of thrombin, which induces membrane
and synaptic changes leading to seizures via PAR1-activation.
However, whether the thrombin-induced increase in neuronal
activity leads to the development of epilepsy at a later stage
remains unclear. Nevertheless, it has been demonstrated that
high concentrations of thrombin induce apoptosis (Xi et al.,
2003; Luo et al., 2007), which may lead to maladaptive circuit
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reorganization and to the development of epilepsy. Additional
work is required to test this intriguing possibility and to assess
whether thrombin could play a crucial role in epileptogenesis.
Open Questions and Conclusions
While robust experimental evidence exists that thrombin
affects brain functioning through the concentration-dependent
regulation of distinct forms of synaptic plasticity, it remains
unclear how thrombin exerts such diverse effects by acting
on the same receptor, i.e., via PAR1. Conceptually, several
possibilities, or a combination of different mechanisms, need to
be considered. In endothelial cells for example the recruitment
of distinct PAR1-mediated downstream signaling pathways
has been reported: while thrombin mediated PAR1-activation
recruits Gq/G12/13, aPC seems to act via PAR1-mediated Gi
(Riewald and Ruf, 2005). This observation is consistent with
a study showing that PAR1 interacts with various G proteins
(Russo et al., 2009; McCoy et al., 2012). Also, precise location
of PAR1 in neuronal or astrocytic membrane compartments
and the current state of neuronal networks seem to influence
selectivity of PAR1 to distinct ligands and the recruitment
of diverse intracellular signaling pathways by PAR1 (Russo
et al., 2009; Bourgognon et al., 2013). Such agonist-biased
signal transduction may explain the involvement of PAR1 in
mediating and influencing various forms of plasticity, depending
on the actual thrombin concentration (Figure 3). However,
whether distinct subtypes of PAR1 exist, which recruit specific
downstream signals, and even show different affinities for
thrombin and aPC needs to be tested. The role of simultaneous
or selective activation of PAR1 in distinct cell types and/or
cellular compartments remains unclear in this context as well.
While some evidence for astrocytic PAR1 signaling has been
provided (e.g., Vance et al., 2015), the contribution of PAR1
signaling in pre- vs. postsynaptic compartments, in distinct types
of interneurons, microglia cells, oligodendrocytes or endothelial
cells warrants further investigation. Thrombin may also exert
its function through other receptors and proteolysis of specific
components in the extracellular matrix (e.g., fibrinogen) under
physiological and pathological conditions (e.g., epileptogenesis,
see Dityatev, 2010). Indeed, evidence exists that fibrinogen plays
an important role in microglia recruitment (Davalos et al.,
2012). Hence, it is interesting to speculate that thrombin could
modulate neuroinflammatory responses by acting on PAR1 and
fibrinogen (Tripathy et al., 2013). Whether thrombin-induced,
fibrin-mediated pathways also act on synaptic transmission and
plasticity, and the role of PAR1 in this context has not been
addressed so far.
Considering the suggested role of thrombin as a major
factor for seizures, the cellular source of thrombin in the brain
and the molecular machinery responsible for its formation
and release needs to be further clarified. Nevertheless, it is
interesting to speculate that new oral anticoagulants, which
target thrombin could have an unexpected antiepileptic effect
(Maggio et al., 2013a), and may restore the ability of neurons to
express plasticity under conditions of increased brain thrombin
concentrations and PAR1-activity, as seen for example upon
BBB breakdown. Its central role in neural plasticity classifies
PAR1 as an interesting therapeutic target in thrombin associated
pathologies. We are confident that future studies will provide
new important insights on the role of thrombin/aPC/PAR1-
mediated neural plasticity and excitability and will shed more
light on concentration-, ligand-, source-, target-, and state-
dependent recruitment of PAR1 signaling cascades. These
information may contribute to the development of new strategies
to restore brain function under pathological conditions.
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